[-] Show simple item record

dc.contributor.authorEgan, Mari E.eng
dc.contributor.authorPrasad, Shailendraeng
dc.contributor.otherFamily Physicians Inquiries Networkeng
dc.date.issued2011-09eng
dc.description.abstractTreat patients with hyperlipidemia and presumed nonalcoholic fatty liver disease with atorvastatin to reduce the risk of cardiovascular events. Stength of recommendation: B: Based on a single prospective randomized controlled trial (RCT).eng
dc.identifier.citationJournal of Family Practice, 60(9) 2011: 536+.eng
dc.identifier.urihttp://hdl.handle.net/10355/11603
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofPriority Updates to Research Literature (PURLs)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectliver diseaseeng
dc.subjectaminotransferase levelseng
dc.subject.lcshHyperlipidemiaeng
dc.subject.lcshStatins (Cardiovascular agents)eng
dc.subject.lcshLiver -- Diseaseseng
dc.titleStatins for patients with nonalcoholic fatty liver?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record